LD

Labmed Dds

BE0741.659.921

Kastanjedreef 8 Oostkamp 8020
Financial ratios
2025
2024
2023
2022
2021
2020
Gross margin
€ 734K
€ 689K
€ 573K
€ 646K
€ 895K
€ 713K
Profit
€ 547K
€ 508K
€ 419K
€ 490K
€ 670K
€ 533K
Equity
€ 198K
€ 101K
€ 108K
€ 1.69M
€ 1.20M
€ 532K
Credit limit
€ 640K
€ 550K
€ 456K
€ 775K
€ 1.02M
€ 787K
Taxes
€ 8K
€ 7K
€ 4K
€ 4K
€ 24K
€ 27K
Salaries and Social Security Contributions
Dividends
€ 450K
€ 515K
€ 2.00M
€ 2K
€ 2K
€ 2K
Dividend payout
82.25%
101.37%
477.14%
0.33%
0.24%
0.30%
EBITDA
€ 732K
€ 686K
€ 569K
€ 644K
€ 893K
€ 712K
EBIT
€ 721K
€ 673K
€ 553K
€ 639K
€ 891K
€ 708K
Net profit
€ 547K
€ 508K
€ 419K
€ 490K
€ 670K
€ 533K
Capex
€ -12K
€ 8K
€ 45K
€ 11K
€ 14K
Cash
€ 413K
€ 259K
€ 306K
€ 606K
€ 893K
€ 381K
Cashflow
€ 558K
€ 521K
€ 435K
€ 495K
€ 672K
€ 537K
Working capital
€ 177K
€ 57K
€ 59K
€ 803K
€ 1.19M
€ 529K
Current ratio
1.41
1.16
1.13
29.11
33.29
5.12
Quick ratio
1.41
1.16
1.13
52.72
39.82
5.33
Working capital ratio
1.41
1.16
1.13
76.50
36.26
5.22
Assets
€ 633K
€ 460K
€ 548K
€ 1.72M
€ 1.24M
€ 660K
Debt
€ 435K
€ 358K
€ 439K
€ 29K
€ 37K
€ 128K
Short-term debt
€ 434K
€ 358K
€ 439K
€ 22K
€ 34K
€ 126K
Long-term debt
Solvability
31.34%
22.04%
19.77%
98.34%
97.03%
80.55%
Long term debt ratio
Debt / EBITDA
0.59
0.52
0.77
0.04
0.04
0.18
Interest Coverage Ratio
Gross profitability
281.39%
514.55%
401.75%
29.31%
56.02%
101.01%
Net profitability
275.78%
501.52%
387.16%
29.03%
55.84%
100.28%
Return On Assets (ROA)
86.44
110.56
76.54
28.55
54.18
80.77
Return On Equity (ROE)
275.78
501.52
387.16
29.03
55.84
100.28
Customer credit
Supplier credit
Days Sales Outstanding (DSO)
Days Sales of Inventory (DSI)
Inventory Turnover Ratio
Employees
Staff cost per employee